Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

about

Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics.Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.

P2860

Q38214156-998BF11C-7541-489F-A4E8-296AC1FF7CE6 Q48146159-F2BAD7A0-5B68-4974-A6E6-B796A02945D9

P2860

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

Item

http://www.wikidata.org/entity/Q48961918

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

@en

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

@nl

type

Item

label

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

@en

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

@nl

prefLabel

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

@en

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

@nl

P1476

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

@en

P2093

Alexander U Brandt

http://www.w3.org/2001/XMLSchema#string

Jan Leo Rinnenthal

http://www.w3.org/2001/XMLSchema#string

Matthias Endres

http://www.w3.org/2001/XMLSchema#string

Sarah Doss

http://www.w3.org/2001/XMLSchema#string

Timm Oberwahrenbrock

http://www.w3.org/2001/XMLSchema#string

P2860

Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes?

Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond.

Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1.

Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1

Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status.

Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.

Atrophy pattern in SCA2 determined by voxel-based morphometry.

Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy

Scale for the assessment and rating of ataxia: development of a new clinical scale.

Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy.

P2888

s12311-013-0527-2

P304

199-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12311-013-0527-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Friedemann Paul

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257301634

http://www.w3.org/2001/XMLSchema#string

P698

24085647

http://www.w3.org/2001/XMLSchema#string

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

about

P2860

P2860

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698